Kluger HM - Search Results

1

Lenvatinib or anti-VEGF in combination with anti-PD-1 differentially augments antitumor activity in melanoma.

Tran TT, Caulfield J, Zhang L, Schoenfeld D, Djureinovic D, Chiang VL, Oria V, Weiss SA, Olino K, Jilaveanu LB, Kluger HM. Tran TT, et al. Among authors: kluger hm. JCI Insight. 2023 Apr 10;8(7):e157347. doi: 10.1172/jci.insight.157347. JCI Insight. 2023. PMID: 36821392 Free PMC article.

2

Expression of sorafenib targets in melanoma patients treated with carboplatin, paclitaxel and sorafenib.

Jilaveanu L, Zito C, Lee SJ, Nathanson KL, Camp RL, Rimm DL, Flaherty KT, Kluger HM. Jilaveanu L, et al. Among authors: kluger hm. Clin Cancer Res. 2009 Feb 1;15(3):1076-85. doi: 10.1158/1078-0432.CCR-08-2280. Clin Cancer Res. 2009. PMID: 19188183 Free PMC article. Clinical Trial.

3

Phosphatidylinositol-3-kinase as a therapeutic target in melanoma.

Aziz SA, Davies M, Pick E, Zito C, Jilaveanu L, Camp RL, Rimm DL, Kluger Y, Kluger HM. Aziz SA, et al. Among authors: kluger y, kluger hm. Clin Cancer Res. 2009 May 1;15(9):3029-36. doi: 10.1158/1078-0432.CCR-08-2768. Epub 2009 Apr 21. Clin Cancer Res. 2009. PMID: 19383818 Free PMC article.

4

C-Raf is associated with disease progression and cell proliferation in a subset of melanomas.

Jilaveanu LB, Zito CR, Aziz SA, Conrad PJ, Schmitz JC, Sznol M, Camp RL, Rimm DL, Kluger HM. Jilaveanu LB, et al. Among authors: kluger hm. Clin Cancer Res. 2009 Sep 15;15(18):5704-13. doi: 10.1158/1078-0432.CCR-09-0198. Epub 2009 Sep 8. Clin Cancer Res. 2009. PMID: 19737955 Free PMC article.

5

Chemotherapy and biologic therapies for melanoma: do they work?

Jilaveanu LB, Aziz SA, Kluger HM. Jilaveanu LB, et al. Among authors: kluger hm. Clin Dermatol. 2009 Nov-Dec;27(6):614-25. doi: 10.1016/j.clindermatol.2008.09.020. Clin Dermatol. 2009. PMID: 19880049 Review.

6

Quantitative expression of VEGF, VEGF-R1, VEGF-R2, and VEGF-R3 in melanoma tissue microarrays.

Mehnert JM, McCarthy MM, Jilaveanu L, Flaherty KT, Aziz S, Camp RL, Rimm DL, Kluger HM. Mehnert JM, et al. Among authors: kluger hm. Hum Pathol. 2010 Mar;41(3):375-84. doi: 10.1016/j.humpath.2009.08.016. Epub 2009 Dec 11. Hum Pathol. 2010. PMID: 20004943 Free PMC article.

7

Vertical targeting of the phosphatidylinositol-3 kinase pathway as a strategy for treating melanoma.

Aziz SA, Jilaveanu LB, Zito C, Camp RL, Rimm DL, Conrad P, Kluger HM. Aziz SA, et al. Among authors: kluger hm. Clin Cancer Res. 2010 Dec 15;16(24):6029-39. doi: 10.1158/1078-0432.CCR-10-1490. Clin Cancer Res. 2010. PMID: 21169255 Free PMC article.

8

A phase 2 trial of dasatinib in advanced melanoma.

Kluger HM, Dudek AZ, McCann C, Ritacco J, Southard N, Jilaveanu LB, Molinaro A, Sznol M. Kluger HM, et al. Cancer. 2011 May 15;117(10):2202-8. doi: 10.1002/cncr.25766. Epub 2010 Nov 29. Cancer. 2011. PMID: 21523734 Free PMC article. Clinical Trial.

9

Melanoma brain metastases: is it time to reassess the bias?

Flanigan JC, Jilaveanu LB, Faries M, Sznol M, Ariyan S, Yu JB, Knisely JP, Chiang VL, Kluger HM. Flanigan JC, et al. Among authors: kluger hm. Curr Probl Cancer. 2011 Jul-Aug;35(4):200-10. doi: 10.1016/j.currproblcancer.2011.07.003. Curr Probl Cancer. 2011. PMID: 21911183 Free PMC article.

10

Multi-level targeting of the phosphatidylinositol-3-kinase pathway in non-small cell lung cancer cells.

Zito CR, Jilaveanu LB, Anagnostou V, Rimm D, Bepler G, Maira SM, Hackl W, Camp R, Kluger HM, Chao HH. Zito CR, et al. Among authors: kluger hm. PLoS One. 2012;7(2):e31331. doi: 10.1371/journal.pone.0031331. Epub 2012 Feb 15. PLoS One. 2012. PMID: 22355357 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

258 results

Search Page

Filters